The Medicare Guarantee Fund appears to be no more than an accounting trick.
The fund is nothing more than a rebadging exercise in the hope people might think it is a new policy. And it's being used to airbrush public hospitals out of the Medicare picture.
Some of the notable additions to the PBS include drugs to treat eye and HIV infections, cystic fibrosis, multiple sclerosis, and cancer.
An independent expert provides his pick of the most notable drugs added to the PBS on May 1, 2017.
PBS headquarters in Arlington, Virginia.
When the Corporation for Public Broadcasting was founded 50 years ago, it was supposed to reflect the nation's disparate voices.
Speech bubbles via shutterstock.com
As the Trump administration settles into office, regulators and lawmakers have big plans for shifting the country's media landscape, with potentially profound effects on the public.
Pharmacists should be trusted to issue repeat prescriptions and adjust dosages, according to a new report.
A Grattan Institute report released today, Cutting a better drug deal, calls for a major shake-up of pharmacies and pharmaceutical pricing.
The government is paying too much for pharmaceuticals that are no better than their cheaper counterparts. Let’s fix that.
Australia is spending more than A$500 million a year too much for pharmaceuticals because of a little known loophole that allows drug companies to overcharge the government.
Australians contribute almost a fifth of all health care spending through fees.
Health policy was an important factor in the election outcome, but one of the most important issues in the health sector – the impact of out-of-pocket costs – was mostly ignored.
Donald Trump answers a question from CNN moderator Wolf Blitzer.
With the presidential debates being derided as evidence we live in a “post-fact" political world, why aren't the moderators “truth vigilantes”?
Australia’s century-old federation is under strain.
If Australia’s new prime minister wishes to lead a successful 21st-century government, he must tackle the rise in chronic disease and use data to constantly improve the system.
Representatives of the 12 Trans-Pacific Partnership (TPP) member countries at a press conference in Atlanta, after a deal was reached.
EPA/Erik S. Lesser
Before the last round of negotiations, only a handful of issues remained in the way of concluding the TPP. A potential deal-breaker for Australia was intellectual property protections for biologics.
The PBAC must make tough decisions about which cancer drugs to subsidise.
Most of us would agree that cancer drugs should be listed on the PBS, no matter how dear. But our health system can't afford all of them. How then are decisions about which drugs to subsidise made?
Off-label use is when an approved medicine is prescribed for a different reason, at a different dose, or in different patient groups than originally intended.
The off-label use of medicines is not illegal and it doesn't mean regulators have specifically "disapproved" its use. But there are a number of issues to consider before using a medicine off-label.
We thought the phone hacking scandal would chasten News Corp. We were wrong.
Israelis protest for Jonathan Pollard’s release.
A group of American airmen broke US laws and evaded the FBI to support the nascent country of Israel in 1948. We should consider them heroes. Jonathan Pollard -- not so much.
PA / PA Archive/PA Images
If you want to see how the market failure model works, look across the Atlantic at PBS and NPR and be afraid.
Insulin, which is used for controlling diabetes and has been in the market for 30 years, was the first biologic.
Biologics are widely accepted as the most effective way of treating certain diseases. They have become the fastest-growing class of therapeutic compounds, with about 300 now available for human use.
A group of oncologists have called on cancer patients to challenge the high prices charged by pharmaceutical companies for new cancer drugs.
Hope, fear, and desperation, along with the unique characteristics of the cancer drug market, create a “perfect storm” that continues to drive up prices for cancer drugs.
The leaked measures would have benefited consumers and taxpayers, with small imposition on the lucrative bottom lines of pharmacists and the pharmaceutical industry.
Despite numerous leaks about impending changes to medicines policy, the budget showed savings of just $252.2 million over five years from adjusting the price of a small number of PBS-listed drugs.
Patients pay a contribution towards the cost of their medication to the pharmacist who then claims the difference between what they paid and the patient contribution from the government.
Australians make an average of 14 visits to the pharmacy for medicines and advice every year but most don't know about the agreement that governs how we buy government-subsidised medicines from them.
A rise in the co-payment for medicines may lead to an increase in the rates of discontinuation for some drugs.
Apart from proposing a co-payment for visiting doctors, the last federal budget also contained a proposal to increase the level of co-payments for medications. The government seems to have given little…